Table 1.
Demographics and Baseline Characteristics (ITT Set)
| Parameter | Total, N = 13 |
|---|---|
| Age, mean ± SD (years) | 3.80 ± 1.76 |
| Body weight, mean ± SD (kg) | 18.12 ± 4.44 |
| FIX treatment prior to enrollment, n (%) | |
| Purified FIX concentrate (IMMUNINE®) | 13 (100) |
| Other high-purity plasma-derived FIX | 6 (46.15) |
| Number of FIX EDs prior to enrollment,a n (%) | |
| 0 days | 0 (0) |
| 1–20 days | 2 (15.38) |
| 21–50 days | 2 (15.38) |
| 51–150 days | 2 (15.38) |
| >150 days | 7 (53.85) |
| FIX level (%) at enrollment,b mean ± SD | 1.92 ± 1.57 |
Notes: aNo patients reported signs of proteinuria. bA value <1% was recorded as 1% in 7 patients.
Abbreviations: ED, exposure day; FIX, factor IX; ITT, intent to treat; SD, standard deviation.